 |
|
|
|
|
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Stefani M. on LIVE DISCUSSION: Microdissection and Microarrays: Analyzing Selective Cell Vulnerability, The theme of selective cell vulnerability in neurodegenerative (but also in other amyloid)... 16 Sep 2010.
|
|
|
 |
|
|
Stefani M. on PAPER: Soscia SJ. et al., 2010, The issue covered in this article is very interesting and reconciles many previous data on... 8 Apr 2009.
|
|
|
|
|
|
Stefani M. on NEWS: Keystone: Death Receptor Ligand—New Role for APP, New Model for AD?, The data reported in this exciting paper can potentially open new ways to interpret AD... 24 Mar 2009.
|
|
|
|
|
|
Stefani M. on NEWS: Spine Shrinkers: Aβ Oligomers Caught in the Act, This is a very important paper illustrating for the first time at high resolution the relation... 16 Feb 2009.
|
|
|
|
|
|
Stefani M. on LIVE DISCUSSION: Calcium in AD Pathogenesis, Several recently appeared papers on the AD-Ca2+ relation have undoubtedly shown that the issue... 29 Oct 2008.
|
|
|
|
|
|
Stefani M. on NEWS: Presenilins Open Escape Hatch for ER Calcium, The work by Bezprozvanny and colleagues undoubtedly adds considerably new information about the... 27 Sep 2006.
|
|
|
|
|
|
Stefani M. on LIVE DISCUSSION: Differential Neuronal Vulnerability, The theme of the differential susceptibility of different cell types to toxic amyloid... 22 Aug 2006.
|
|
|
|
|
|
Stefani M. on NEWS: Omega-3 Fatty Acid Target Identified in Neurite Extension, The paper by Darios and Davletov provides significant information on the triggers of cell... 18 Apr 2006.
|
|
|
|
|
|
Stefani M. on LIVE DISCUSSION: The Pathogen Hypothesis—Challenging the Primacy of Genetics in Late-Onset Alzheimer Disease., The background article by Brian Balin on the possible microbial cause of Alzheimer disease (AD)... 1 Sep 2005.
|
|
|
|
|
|
Stefani M. on NEWS: Aβ—Pinning Down Protofibrils, Indeed, since some time I have been thinking about the need to search for protofibril... 10 May 2005.
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
